Jop H. van Berlo

6.4k citations

55 papers · 4.4k indexed · 4 hit papers · h-index 25

Molecular Biology top 2%
Cardiology and Cardiovascular Medicine top 1%
Surgery top 5%
Immunology top 5%
Oncology top 10%

Co-authors: Jeffery D. Molkentin Marjorie Maillet Yigal M. Pinto Harry J.G.M. Crijns Onur Kanisicak Federica Accornero Ronald J. Vagnozzi Saraswati Pokharel
Topics: Congenital heart defects research (22 papers)Cardiac Fibrosis and Remodeling (17 papers)Tissue Engineering and Regenerative Medicine (11 papers)
Cited by: Cardiology and Cardiovascular Medicine Molecular Biology Immunology
Journals: Nature Proceedings of the National Academy of Sciences Circulation
Partner nations: United States Netherlands United Kingdom

In The Last Decade

Jop H. van Berlo

51 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction

2004 735 citations Jop H. van Berlo, Harry J.G.M. Crijns et al. Circulation profile →
c-kit+ cells minimally contribute cardiomyocytes to the heart

2014 579 citations Jop H. van Berlo, Onur Kanisicak et al. profile →
Molecular basis of physiological heart growth: fundamental concepts and new players

2012 406 citations Marjorie Maillet, Jop H. van Berlo et al. profile →
The N ⁶ -Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

2019 324 citations Jop H. van Berlo, Federica Accornero et al. Circulation profile →

Peers

Countries citing papers authored by Jop H. van Berlo

Since Specialization

Citations

This map shows the geographic impact of Jop H. van Berlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jop H. van Berlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jop H. van Berlo more than expected).

Fields of papers citing papers by Jop H. van Berlo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jop H. van Berlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jop H. van Berlo. The network helps show where Jop H. van Berlo may publish in the future.

Co-authorship network of co-authors of Jop H. van Berlo

This figure shows the co-authorship network connecting the top 25 collaborators of Jop H. van Berlo. A scholar is included among the top collaborators of Jop H. van Berlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jop H. van Berlo. Jop H. van Berlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Cardiohepatic Axis in Metabolic Disease 2025 ·JACC Basic to Translational Science ·(unknown),Jop H. van Berlo,Xavier S. Revelo	0
2	Macrophage-Derived CCL24 Promotes Cardiac Fibrosis Via Fibroblast CCR3 2025 ·Circulation Research ·(unknown),Fanta Barrow,Haiguang Wang,Upendra Chalise,Natália Araújo,(unknown),Huy Truong Nguyen,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Sang‐Hun Lee,Adam Herman,Marc E. Rothenberg,Samuel C. Dudley,Jop H. van Berlo,Xavier S. Revelo	3
3	Advances in Drug Discovery for Cardiomyocyte Proliferation 2025 ·Current Treatment Options in Cardiovascular Medicine ·(unknown),Matthew J. Wolf,Jop H. van Berlo,Jeffrey J. Saucerman	1
4	Proliferation and Maturation: Janus and the Art of Cardiac Tissue Engineering 2023 ·Circulation Research ·Bhairab N. Singh,(unknown),Bayardo I. Garay,Elena G. Tolkacheva,Michael Kyba,Rita C. R. Perlingeiro,Jop H. van Berlo,Brenda M. Ogle	23
5	Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes 2022 ·Stem Cell Reports ·Bayardo I. Garay,(unknown),Phablo Abreu,Man Liu,(unknown),June Baik,(unknown),(unknown),Alessandro Magli,Juan E. Abrahante,Natalya A. Goloviznina,(unknown),Neha R. Dhoke,Michael Kyba,Patrick W. Alford,Samuel C. Dudley,Jop H. van Berlo,Brenda M. Ogle,Rita Perlingeiro	25
6	Abstract 9531: Septin4 Deletion Prevents Hypertrophy to Heart Failure Transition After Transverse Aortic Constriction 2021 ·Circulation ·(unknown),(unknown),An Xie,Jop H. van Berlo	1
7	Genetic Lineage Tracing of Non-cardiomyocytes in Mice 2020 ·Methods in molecular biology ·Zhongming Chen,Jop H. van Berlo	1
8	Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis 2020 ·Journal of Visualized Experiments ·(unknown),(unknown),Jop H. van Berlo	6
9	The Role of TGF—β Signaling in Cardiomyocyte Proliferation 2020 ·Current Heart Failure Reports ·(unknown),Jop H. van Berlo	25
10	Development of a Click-Chemistry Reagent Compatible with Mass Cytometry 2018 ·Scientific Reports ·(unknown),(unknown),Heather M. Brown,Edgar A. Arriaga,Valérie C. Pierre,Jop H. van Berlo	6
11	A conserved HH-Gli1-Mycn network regulates heart regeneration from newt to human 2018 ·Nature Communications ·Bhairab N. Singh,Naoko Koyano‐Nakagawa,Wuming Gong,Ivan P. Moskowitz,Cyprian Weaver,Elizabeth Braunlin,Satyabrata Das,Jop H. van Berlo,Mary G. Garry,Daniel J. Garry	52
12	BEX1 is an RNA-dependent mediator of cardiomyopathy 2017 ·Nature Communications ·Federica Accornero,Tobias G. Schips,Jennifer M. Petrosino,(unknown),Onur Kanisicak,Jop H. van Berlo,Jeffery D. Molkentin	27
13	An emerging consensus on cardiac regeneration 2014 ·Nature Medicine ·Jop H. van Berlo,Jeffery D. Molkentin	180
14	Signaling effectors underlying pathologic growth and remodeling of the heart 2013 ·Journal of Clinical Investigation ·Jop H. van Berlo,Marjorie Maillet,Jeffery D. Molkentin	340
15	Parsing the Roles of the Transcription Factors GATA-4 and GATA-6 in the Adult Cardiac Hypertrophic Response 2013 ·PLoS ONE ·Jop H. van Berlo,Bruce J. Aronow,Jeffery D. Molkentin	28
16	AB26-1 2006 ·Heart Rhythm ·Frédéric Anselme,(unknown),Jop H. van Berlo,Gisèle Bonne,Arnaud Savouré,Rabah Ben Yaou,J. Peter van Tintelen,Henri-Marc Bécane,Maarten P. van den Berg,Pascal Laforêt,Alain Cribier,(unknown),Denis Duboc	1
17	A-type lamins are essential for TGF-β1 induced PP2A to dephosphorylate transcription factors 2005 ·Human Molecular Genetics ·Jop H. van Berlo,Jan Willem Voncken,Nard Kubben,Jos L. V. Broers,Rudy F. Duisters,Rick E.W. van Leeuwen,Harry J.G.M. Crijns,Frans C. S. Ramaekers,Christopher J. Hutchison,Yigal M. Pinto	129
18	Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? 2004 ·Journal of Molecular Medicine ·Jop H. van Berlo,Willem G. de Voogt,Anneke J. van der Kooi,J. Peter van Tintelen,Gisèle Bonne,Rabah Ben Yaou,Denis Duboc,Tom Rossenbacker,Hein Heidbüchel,Marjolein Visser,Harry J.G.M. Crijns,Yigal M. Pinto	301
19	Sudden death can not be prevented by pacemaker therapy in patients with lamin A/C mutations 2002 ·Data Archiving and Networked Services (DANS) ·(unknown),(unknown),(unknown),(unknown),M. Visser,(unknown),Jop H. van Berlo	2
20	Clinical characteristics of genetic dilated cardiomyopathy differ between sarcomeric and non-sarcomeric gene mutations 2002 ·Data Archiving and Networked Services (DANS) ·Robert Vlietinck,(unknown),(unknown),(unknown),Jop H. van Berlo	1

About Jop H. van Berlo

Jop H. van Berlo is a scholar working on Cardiology and Cardiovascular Medicine, Structural Biology and Molecular Biology, having authored 55 papers that have together received 4.4k indexed citations. Recurring topics across this work include Congenital heart defects research (22 papers), Cardiac Fibrosis and Remodeling (17 papers) and Tissue Engineering and Regenerative Medicine (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.6k citations), Molecular Biology (3.0k citations) and Immunology (632 citations). Jop H. van Berlo has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Jeffery D. Molkentin, Marjorie Maillet, Yigal M. Pinto, Harry J.G.M. Crijns, Onur Kanisicak, Federica Accornero, Ronald J. Vagnozzi, Saraswati Pokharel, Umesh C. Sharma and Thomas J. van Brakel. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact